Ellington Credit Co. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Ellington Credit Company (the "Fund") on March 26, 2026, covering events occurring on March 25, 2026. The Fund is a closed-end management investment company incorporated in Delaware, with common shares trading on the New York Stock Exchange under the symbol "EARN".
Key Financial Metrics and Transaction Details
The filing details a new debt issuance rather than reporting periodic financial performance metrics such as revenue or net income. Key transaction figures include:
- Debt Issuance: $50 million aggregate principal amount of 8.50% Notes due 2031.
- Over-Allotment Option: Underwriters granted an option to purchase up to an additional $7.5 million of the Notes.
- Expected Closing: March 30, 2026.
- Trading Symbol for Notes: "ELLA" (expected listing on NYSE within 30 days).
- Use of Proceeds: General corporate purposes, specifically funding asset purchases and repaying short-term borrowings under reverse repurchase agreements.
The filing text does not provide current values for total revenue, profit, cash flow, margins, or existing total debt levels.
Material Changes
The primary material change is the entry into a definitive underwriting agreement to raise long-term capital. This transaction will increase the Fund's leverage and alter its capital structure upon closing. The Fund intends to use these proceeds to reduce reliance on short-term reverse repurchase agreements for financing its investment portfolio.
Outlook, Risks, and Management Commentary
Management has indicated the offering is intended to support the Fund's investment objectives and strategies. The transaction is subject to customary closing conditions. The filing includes standard indemnification agreements with underwriters against liabilities under the Securities Act of 1933. No specific risks or contingencies beyond standard offering conditions were detailed in the text of this 8-K.
Investor Verification Checklist
- Verify the final closing date of the $50 million offering (expected March 30, 2026).
- Confirm whether the underwriters exercised the $7.5 million over-allotment option.
- Review the Fund's most recent quarterly report (Form N-Q or 10-Q) to assess the impact of this new debt on total leverage ratios.
- Monitor the listing status of the new "ELLA" notes on the NYSE.
- Check subsequent filings for the actual amount of short-term borrowings repaid using the proceeds.